+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

PS01.37: Comparison Between Sanger Sequencing and ARMS qPCR Method for EGFR Gene Mutation Detection of Non-Small Cell Lung Cancer: Topic: Medical Oncology



PS01.37: Comparison Between Sanger Sequencing and ARMS qPCR Method for EGFR Gene Mutation Detection of Non-Small Cell Lung Cancer: Topic: Medical Oncology



Journal of Thoracic Oncology 11(11s): S291-S292




(PDF emailed within 0-6 h: $19.90)

Accession: 060149457

Download citation: RISBibTeXText

PMID: 27969504

DOI: 10.1016/j.jtho.2016.09.072


Related references

PS01.65: EGFR Exon 19 Deletion Mutation Patients Obtain Optimal Survival in Icotinib Treated Non-Small Cell Lung Cancer Patient with Brain Metastases: Topic: Medical Oncology. Journal of Thoracic Oncology 11(11s): S311-S311, 2016

PS01.74: Systemic Treatment Sequencing in US Medicare Patients with Extensive Disease (ED)-Small Cell Lung Cancer (SCLC): Topic: Medical Oncology. Journal of Thoracic Oncology 11(11s): S317-S318, 2016

PS01.69: Indirect Naive Comparison of ALK Inhibitors for ALK+ Non-Small Cell Lung Cancer (NSCLC) Post-Crizotinib Failure: Topic: Medical Oncology. Journal of Thoracic Oncology 11(11s): S313-S314, 2016

PS01.29: The EGFR-mTOR Signaling Axis: a Prognostic Biomarker in Non-Small Cell Lung Carcinoma at the Time of Diagnosis: Topic: Medical Oncology. Journal of Thoracic Oncology 11(11s): S286-S287, 2016

PS01.36: Blood-Based Mutation Testing in Non-Small Cell Lung Carcinoma Patients Supports Individualized and Optimal Treatment: Topic: Medical Oncology. Journal of Thoracic Oncology 11(11s): S291-S291, 2016

A comparison of direct sequencing and ARMS assay performance in EGFR mutation analysis of non-small cell lung cancer patients. Zhongguo Fei Ai Za Zhi 17(8): 606-611, 2015

PS01.03: Referral Practices of Medical Oncologists to Palliative Care for Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC): Topic: Medical Oncology. Journal of Thoracic Oncology 11(11s): S271-S271, 2016

PS01.63: Clinical Characteristics of Acquired Resistance with Anti-PD-1/PD-L1 in Non-Small Cell Lung Cancer (NSCLC): Topic: Medical Oncology. Journal of Thoracic Oncology 11(11s): S310-S310, 2016

PS01.73: Have We Shifted the Therapeutic Innovation Frontier? A US Assessment of Advanced Non-Small Cell Lung Cancer (advNSCLC): Topic: Medical Oncology. Journal of Thoracic Oncology 11(11s): S316-S317, 2016

PS01.68: Heterogeneous Clinical Syndromes Existing Within Patients with Stage IV KRAS Mutant Non-Small Cell Lung Cancer: Topic: Medical Oncology. Journal of Thoracic Oncology 11(11s): S313-S313, 2016

PS01.76: Impact of Chemotherapy Intensity on Progression and Survival in Metastatic Non-Small Cell Lung Cancer: A Systematic Review: Topic: Medical Oncology. Journal of Thoracic Oncology 11(11s): S319-S319, 2016

PS01.75: Safety Outcomes in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Platinum-Based Regimens in the US: Topic: Medical Oncology. Journal of Thoracic Oncology 11(11s): S318-S318, 2016

Comparison of EGFR mutation status between plasma and tumor tissue in non-small cell lung cancer using the Scorpion ARMS method and the possible prognostic significance of plasma EGFR mutation status. International Journal of Clinical and Experimental Pathology 8(10): 13136-13145, 2016

PS01.72: Payer and Patient Out-of-Pocket Costs: A Projection of the Financial Burden of Non-Small Cell Lung Cancer Care in the United States Through 2040: Topic: Medical Oncology. Journal of Thoracic Oncology 11(11s): S315-S316, 2016

A comparison of ARMS and direct sequencing for EGFR mutation analysis and tyrosine kinase inhibitors treatment prediction in body fluid samples of non-small-cell lung cancer patients. Journal of Experimental & Clinical Cancer Research 30: 111-111, 2012